These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27930497)

  • 1. The COMT Val158Met Polymorphism Is Associated With Response to Add-on Dextromethorphan Treatment in Bipolar Disorder.
    Lee SY; Chen SL; Wang TY; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Chen KC; Yang YK; Lu RB
    J Clin Psychopharmacol; 2017 Feb; 37(1):94-98. PubMed ID: 27930497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DRD2/ANKK1 gene is associated with response to add-on dextromethorphan treatment in bipolar disorder.
    Lee SY; Chen SL; Chang YH; Chen SH; Chu CH; Huang SY; Tzeng NS; Wang CL; Lee IH; Yeh TL; Yang YK; Lu RB
    J Affect Disord; 2012 May; 138(3):295-300. PubMed ID: 22326841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype variant associated with add-on memantine in bipolar II disorder.
    Lee SY; Chen SL; Chang YH; Chen SH; Chu CH; Huang SY; Tzeng NS; Wang CL; Wang LJ; Lee IH; Yeh TL; Yang YK; Hong JS; Lu RB
    Int J Neuropsychopharmacol; 2014 Feb; 17(2):189-97. PubMed ID: 24103632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: a 12-week double-blind, randomized controlled trial.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Wang TY; Yeh TL; Yang YK; Hong JS; Lu RB
    J Clin Psychopharmacol; 2014 Jun; 34(3):337-43. PubMed ID: 24717258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of add-on low-dose dextromethorphan plus valproic acid in bipolar disorder.
    Chen SL; Lee SY; Chang YH; Chen PS; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1753-9. PubMed ID: 25262178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Yeh TL; Yang YK; Lu RB; Hong JS
    J Psychiatr Res; 2013 Oct; 47(10):1343-8. PubMed ID: 23870798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catechol-O-methyltransferase Val158Met polymorphism affects therapeutic response to mood stabilizer in symptomatic manic patients.
    Lee HY; Kim YK
    Psychiatry Res; 2010 Jan; 175(1-2):63-6. PubMed ID: 20004480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The catechol-O-methyltransferase (COMT) Val158Met genotype modulates working memory-related dorsolateral prefrontal response and performance in bipolar disorder.
    Miskowiak KW; Kjaerstad HL; Støttrup MM; Svendsen AM; Demant KM; Hoeffding LK; Werge TM; Burdick KE; Domschke K; Carvalho AF; Vieta E; Vinberg M; Kessing LV; Siebner HR; Macoveanu J
    Bipolar Disord; 2017 May; 19(3):214-224. PubMed ID: 28544426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALDH2 polymorphism, associated with attenuating negative symptoms in patients with schizophrenia treated with add-on dextromethorphan.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
    J Psychiatr Res; 2015 Oct; 69():50-6. PubMed ID: 26343594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The COMT and DRD3 genes interacted in bipolar I but not bipolar II disorder.
    Lee SY; Chen SL; Chen SH; Huang SY; Tzeng NS; Chang YH; Wang CL; Lee IH; Yeh TL; Yang YK; Lu RB
    World J Biol Psychiatry; 2011 Aug; 12(5):385-91. PubMed ID: 20698735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the COMT synonymous polymorphism Leu136Leu and missense variant Val158Met with mood disorders.
    Pandolfo G; Gugliandolo A; Gangemi C; Arrigo R; Currò M; La Ciura G; Muscatello MR; Bruno A; Zoccali R; Caccamo D
    J Affect Disord; 2015 May; 177():108-13. PubMed ID: 25766270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the COMT val158met variant with antidepressant treatment response in major depression.
    Baune BT; Hohoff C; Berger K; Neumann A; Mortensen S; Roehrs T; Deckert J; Arolt V; Domschke K
    Neuropsychopharmacology; 2008 Mar; 33(4):924-32. PubMed ID: 17522626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder.
    Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Cole S; Leister F; Krivogorsky B; Yolken RH
    Bipolar Disord; 2006 Apr; 8(2):124-32. PubMed ID: 16542182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexually dimorphic effect of catechol-O-methyltransferase val158met polymorphism on clinical response to fluoxetine in major depressive patients.
    Tsai SJ; Gau YT; Hong CJ; Liou YJ; Yu YW; Chen TJ
    J Affect Disord; 2009 Feb; 113(1-2):183-7. PubMed ID: 18533273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COMT and BDNF interacted in bipolar II disorder not comorbid with anxiety disorder.
    Lee SY; Chen SL; Wang YS; Chang YH; Huang SY; Tzeng NS; Lee IH; Yeh TL; Yang YK; Lu RB
    Behav Brain Res; 2013 Jan; 237():243-8. PubMed ID: 23026378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of the Val158Met catechol-O-methyltransferase polymorphism on the personality traits of bipolar patients.
    Dávila W; Basterreche N; Arrue A; Zamalloa MI; Gordo E; Dávila R; González-Torres MA; Zumárraga M
    PLoS One; 2013; 8(4):e62900. PubMed ID: 23646156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechol-O-methyltransferase Val158Met polymorphism influences anxiety, depression, and disability, but not pressure pain sensitivity, in women with fibromyalgia syndrome.
    Fernández-de-Las-Peñas C; Ambite-Quesada S; Gil-Crujera A; Cigarán-Méndez M; Peñacoba-Puente C
    J Pain; 2012 Nov; 13(11):1068-74. PubMed ID: 23025981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memantine as an Adjuvant Treatment for Obsessive Compulsive Symptoms in Manic Phase of Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Sahraian A; Jahromi LR; Ghanizadeh A; Mowla A
    J Clin Psychopharmacol; 2017 Apr; 37(2):246-249. PubMed ID: 28099183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential association of the COMT Val158Met polymorphism with clinical phenotypes in schizophrenia and bipolar disorder.
    Goghari VM; Sponheim SR
    Schizophr Res; 2008 Aug; 103(1-3):186-91. PubMed ID: 18571901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catechol-O-methyltransferase Val158Met polymorphism and altered COMT gene expression in the prefrontal cortex of suicide brains.
    Du L; Merali Z; Poulter MO; Palkovits M; Faludi G; Anisman H
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():178-83. PubMed ID: 24389396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.